Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record version was updated to v3.5.3, replacing the previous v3.5.2.SummaryDifference0.1%

- Check25 days agoChange DetectedUpdated the site revision/version indicator from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history log.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry, v3.4.3, was added and the previous revision entry, v3.4.2, was removed from the history.SummaryDifference0.1%

- Check89 days agoChange DetectedOnly the addition of a new revision tag (v3.4.2) and removal of the previous revision (v3.4.1) are visible; no study data, status, or content changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange DetectedThe revision history shows the addition of Revision: v3.4.1 and removal of Revision: v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.